** Shares of Sihuan Pharmaceutical Holdings Group Ltd 0460.HK fall 3.4% to HK$0.56, extending losses for a second session
** Stock posts its biggest intraday pct drop since Jan 22
** Sihuan expects to record revenue of not less than 1.80 bln yuan ($248.25 mln) and a net loss of not more than 600 mln yuan for 2024, as generic drug business declines amid centralized procurement policy in the mainland and high R&D expenses
** This compares with a revenue of 1.86 bln yuan and a net loss of 54 mln yuan in 2023
** Hang Seng Commerce & Industry Index .HSNC rises 1.7%, healthcare index .HSCIH gains 0.5% and Hang Seng Index .HSI adds 1%
** Stock climbed 1.5% last year
($1 = 7.2507 Chinese yuan)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。